AlzChem Group (ACT) Stock Overview
Develops, produces, and markets a range of chemical specialties in Germany, European Union, rest of Europe, Asia, NAFTA region, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 4/6 |
| Past Performance | 6/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
Rewards
Risk Analysis
No risks detected for ACT from our risk checks.
ACT Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
AlzChem Group AG Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €150.20 |
| 52 Week High | €166.40 |
| 52 Week Low | €50.80 |
| Beta | 0.64 |
| 1 Month Change | 9.80% |
| 3 Month Change | 2.04% |
| 1 Year Change | 189.96% |
| 3 Year Change | 881.70% |
| 5 Year Change | 636.27% |
| Change since IPO | 458.57% |
Recent News & Updates
Recent updates
Shareholder Returns
| ACT | DE Chemicals | DE Market | |
|---|---|---|---|
| 7D | 3.0% | 2.8% | 2.6% |
| 1Y | 190.0% | -14.6% | 14.7% |
Return vs Industry: ACT exceeded the German Chemicals industry which returned -14.7% over the past year.
Return vs Market: ACT exceeded the German Market which returned 14.6% over the past year.
Price Volatility
| ACT volatility | |
|---|---|
| ACT Average Weekly Movement | 7.0% |
| Chemicals Industry Average Movement | 4.3% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 12.3% |
| 10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: ACT has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: ACT's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1908 | 1,647 | Andreas Niedermaier | www.alzchem.com |
AlzChem Group AG, together with its subsidiaries, develops, produces, and markets a range of chemical specialties in Germany, European Union, rest of Europe, Asia, NAFTA region, and internationally. It operates through three segments: Specialty Chemicals, Basics & Intermediates, and Other & Holding. The Specialty Chemicals segment sells specialty chemical products that are used in the chemical, food, animal feed, defence technology, and renewable energies industries.
AlzChem Group AG Fundamentals Summary
| ACT fundamental statistics | |
|---|---|
| Market cap | €1.51b |
| Earnings (TTM) | €57.92m |
| Revenue (TTM) | €566.25m |
Is ACT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ACT income statement (TTM) | |
|---|---|
| Revenue | €566.25m |
| Cost of Revenue | €207.72m |
| Gross Profit | €358.53m |
| Other Expenses | €300.61m |
| Earnings | €57.92m |
Last Reported Earnings
Jun 30, 2025
Next Earnings Date
Oct 30, 2025
| Earnings per share (EPS) | 5.71 |
| Gross Margin | 63.32% |
| Net Profit Margin | 10.23% |
| Debt/Equity Ratio | 20.2% |
How did ACT perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/10/06 08:11 |
| End of Day Share Price | 2025/10/03 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
AlzChem Group AG is covered by 7 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Volker Bosse | Baader Helvea Equity Research |
| Konstantin Wiechert | Baader Helvea Equity Research |
| Gerhard Orgonas | Berenberg |